Investigation of the effect of subacromial corticosteroid injections on intraocular pressure

Basit Öğe Kaydı
dc.authorscopusid57202582882en_US
dc.authorscopusid57204495925en_US
dc.authorscopusid58718504600en_US
dc.authorscopusid24399934200en_US
dc.authorscopusid6601917736en_US
dc.authorwosidEngin, Onur/HHY-9967-2022en_US
dc.contributor.authorEngin, Onur
dc.contributor.authorEngin, Ceren Durmaz
dc.contributor.authorSamanci, Rumeysa
dc.contributor.authorTeberik, Kuddusi
dc.contributor.authorAtaoglu, Safinaz
dc.date.accessioned2024-08-23T16:04:19Z
dc.date.available2024-08-23T16:04:19Z
dc.date.issued2023en_US
dc.departmentDüzce Üniversitesien_US
dc.description.abstractBackground:Subacromial corticosteroid injection is one of the most commonly used procedures to treat subacromial impingement syndrome. Despite their significant efficacy, corticosteroids have several serious adverse effects, including increased intraocular pressure (IOP) and visual loss. The purpose of this study is to determine the effect of subacromial corticosteroid injections on IOP.Materials and Methods:42 patients with impingement syndrome, who received subacromial corticosteroid injection, were included in the study. Patients received a single dose of betamethasone. IOP was monitored using a tonometer prior to injection, 24 hours after injection, and one week following injection.Results:The average age of the patients was 52.1 +/- 9.0, and 31 (74%) of them were female. Patients' mean IOP values were 16.0 +/- 2.6 mmHg, 16.4 +/- 2.4 mmHg, and 16.1 +/- 2.31 mmHg before injection, one day after injection, and one week after injection, respectively. Repeated ANOVA tests revealed no statistically significant difference between the three measurements (P=0.386). Age, gender, history of diabetes, and history of hypertension didn't have a significant effect on IOP change after corticosteroid injection. Those with a family history of glaucoma had a significantly greater increase in IOP on day 1 post-injection than those without (P=0.05).Conclusions:This is the first study to examine the effect of subacromial corticosteroid injections on IOP change. While a single subacromial steroid injection has no statistically significant effect on IOP change, care should be taken, particularly in susceptible individuals and those who need repeated injections.en_US
dc.identifier.doi10.1097/BCO.0000000000001219
dc.identifier.endpage310en_US
dc.identifier.issn1940-7041
dc.identifier.issn1941-7551
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-85177749713en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage307en_US
dc.identifier.urihttps://doi.org/10.1097/BCO.0000000000001219
dc.identifier.urihttps://hdl.handle.net/20.500.12684/14166
dc.identifier.volume34en_US
dc.identifier.wosWOS:001124056300008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofCurrent Orthopaedic Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectinjectionsen_US
dc.subjectintraocular pressureen_US
dc.subjectrotator cuffen_US
dc.subjectsteroiden_US
dc.subjectInduced Glaucomaen_US
dc.subjectMethylprednisoloneen_US
dc.titleInvestigation of the effect of subacromial corticosteroid injections on intraocular pressureen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu